Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00382_DB01059_nanopub.RAGvujwHYxiKS-ZutSO4v6Ctsz8LL9JlLM7DDSYg3aLXo#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00382_DB01059 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00382_DB01059 label "DDI between Tacrine and Norfloxacin - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Norfloxacin. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Norfloxacin is initiated, discontinued or if the dose is changed. [drugbank_resource:DB00382_DB01059]" assertion.
- drugbank_resource:DB00382_DB01059 identifier "drugbank_resource:DB00382_DB01059" assertion.
- drugbank_resource:DB00382_DB01059 title "DDI between Tacrine and Norfloxacin - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Norfloxacin. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Norfloxacin is initiated, discontinued or if the dose is changed." assertion.
- drugbank:DB00382 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB01059 assertion.
- drugbank:DB01059 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB01059 assertion.